The pharmacotherapy of ischemic heart disease has evolved at a rapid pace during the past several decades. Drug therapy is prescribed for ischemic heart disease to either increase myocardial oxygen supply, decrease myocardial oxygen demand, or both. Although the types and number of drugs to treat ischemic heart disease are increasing and will continue to do so, there are still several major categories of pharmacologic agents that are essential in managing ischemic heart disease. The major drug categories covered are antiplatelet agents, anticoagulants, nitrates, beta-adrenergic receptor antagonists (beta-blockers), calcium channel antagonists, angiotensin-converting enzyme inhibitors, and thrombolytic agents. Current Information and recommendations are presented for safe and effective use of these agents
Skip Nav Destination
Ischemic Heart Disease| August 01 1995
Pharmacotherapy of Ischemic Heart Disease
James R. Clem, PharmD
From the College of Pharmacy, South Dakota State University, Brookings, South Dakota.
Reprint requests to James R. Clem, PharmD, Department of Pharmaceutical Services, Sioux Valley Hospital, 1100 S. Euclid Ave., P.O. Box 5039, Sioux Falls, SD 57117-5039.
Search for other works by this author on:
AACN Adv Crit Care (1995) 6 (3): 404–417.
- Views Icon Views
- Share Icon Share
James R. Clem; Pharmacotherapy of Ischemic Heart Disease. AACN Adv Crit Care 1 August 1995; 6 (3): 404–417. doi:
Download citation file: